BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 29156912)

  • 1. Genetic biomarkers associated with pain flare and dexamethasone response following palliative radiotherapy in patients with painful bone metastases.
    Furfari A; Wan BA; Ding K; Wong A; Zhu L; Bezjak A; Wong R; Wilson CF; DeAngelis C; Azad A; Chow E; Charames GS
    Ann Palliat Med; 2017 Dec; 6(Suppl 2):S240-S247. PubMed ID: 29156912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic biomarkers associated with changes in quality of life and pain following palliative radiotherapy in patients with bone metastases.
    Furfari A; Wan BA; Ding K; Wong A; Zhu L; Bezjak A; Wong R; Wilson CF; DeAngelis C; Azad A; Chow E; Charames GS
    Ann Palliat Med; 2017 Dec; 6(Suppl 2):S248-S256. PubMed ID: 29156910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic biomarkers associated with response to palliative radiotherapy in patients with painful bone metastases.
    Furfari A; Wan BA; Ding K; Wong A; Zhu L; Bezjak A; Wong R; Wilson CF; DeAngelis C; Azad A; Chow E; Charames GS
    Ann Palliat Med; 2017 Dec; 6(Suppl 2):S233-S239. PubMed ID: 29156909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexamethasone in the prophylaxis of radiation-induced pain flare after palliative radiotherapy for bone metastases: a double-blind, randomised placebo-controlled, phase 3 trial.
    Chow E; Meyer RM; Ding K; Nabid A; Chabot P; Wong P; Ahmed S; Kuk J; Dar AR; Mahmud A; Fairchild A; Wilson CF; Wu JSY; Dennis K; Brundage M; DeAngelis C; Wong RKS
    Lancet Oncol; 2015 Nov; 16(15):1463-1472. PubMed ID: 26489389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dexamethasone for the prevention of a pain flare after palliative radiotherapy for painful bone metastases: a multicenter double-blind placebo-controlled randomized trial.
    Westhoff PG; de Graeff A; Geerling JI; Reyners AK; van der Linden YM
    BMC Cancer; 2014 May; 14():347. PubMed ID: 24885354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should dexamethasone be standard in the prophylaxis of pain flare after palliative radiotherapy for bone metastases?-a debate.
    Niglas M; Raman S; Rodin D; Detsky J; DeAngelis C; Soliman H; Chow E; Tsao MN
    Ann Palliat Med; 2018 Apr; 7(2):279-283. PubMed ID: 28595438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexamethasone for the Prevention of a Pain Flare After Palliative Radiation Therapy for Painful Bone Metastases: The Multicenter Double-Blind Placebo-Controlled 3-Armed Randomized Dutch DEXA Study.
    van der Linden YM; Westhoff PG; Stellato RK; van Baardwijk A; de Vries K; Ong F; Wiggenraad R; Bakri B; Wester G; de Pree I; van Veelen L; Budiharto T; Schippers M; Reyners AKL; de Graeff A
    Int J Radiat Oncol Biol Phys; 2020 Nov; 108(3):546-553. PubMed ID: 32446951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexamethasone for the prophylaxis of radiation-induced pain flare after palliative radiotherapy for bone metastases: a pilot study.
    Chow E; Loblaw A; Harris K; Doyle M; Goh P; Chiu H; Panzarella T; Tsao M; Barnes EA; Sinclair E; Farhadian M; Danjoux C
    Support Care Cancer; 2007 Jun; 15(6):643-647. PubMed ID: 17242910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexamethasone for the prophylaxis of radiation-induced pain flare after palliative radiotherapy for symptomatic bone metastases: a phase II study.
    Hird A; Zhang L; Holt T; Fairchild A; DeAngelis C; Loblaw A; Wong R; Barnes E; Tsao M; Danjoux C; Chow E
    Clin Oncol (R Coll Radiol); 2009 May; 21(4):329-35. PubMed ID: 19232483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary cytokines/chemokines pattern in patients with painful bone metastases undergoing external beam radiotherapy experiencing pain flare.
    Bushehri A; Chow E; Zhang L; Azad A; Vuong S; Pasetka M; Zhou M; Hird A; Dennis K; McDonald R; DeAngelis C
    Ann Palliat Med; 2016 Apr; 5(2):107-15. PubMed ID: 27121738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of pain flare following palliative radiotherapy for symptomatic bone metastases: multicenter prospective observational study.
    Gomez-Iturriaga A; Cacicedo J; Navarro A; Morillo V; Willisch P; Carvajal C; Hortelano E; Lopez-Guerra JL; Illescas A; Casquero F; Del Hoyo O; Ciervide R; Irasarri A; Pijoan JI; Bilbao P
    BMC Palliat Care; 2015 Oct; 14():48. PubMed ID: 26427616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Radiotherapy on Painful Bone Metastases: A Secondary Analysis of the NCIC Clinical Trials Group Symptom Control Trial SC.23.
    McDonald R; Ding K; Brundage M; Meyer RM; Nabid A; Chabot P; Coulombe G; Ahmed S; Kuk J; Dar AR; Mahmud A; Fairchild A; Wilson CF; Wu JSY; Dennis K; DeAngelis C; Wong RKS; Zhu L; Chan S; Chow E
    JAMA Oncol; 2017 Jul; 3(7):953-959. PubMed ID: 28196208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pain Flare-Effect Prophylaxis With Corticosteroids on Bone Radiotherapy Treatment: A Systematic Review.
    Fabregat C; Almendros S; Navarro-Martin A; Gonzalez J
    Pain Pract; 2020 Jan; 20(1):101-109. PubMed ID: 31342618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determining the incidence of pain flare following palliative radiotherapy for symptomatic bone metastases: results from three canadian cancer centers.
    Hird A; Chow E; Zhang L; Wong R; Wu J; Sinclair E; Danjoux C; Tsao M; Barnes E; Loblaw A
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):193-7. PubMed ID: 19167840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient Reported Outcomes After Radiation Therapy for Bone Metastases as a Function of Age: A Secondary Analysis of the NCIC CTG SC-Twenty-Three Randomized Trial.
    Chow S; Ding K; Wan BA; Brundage M; Meyer RM; Nabid A; Chabot P; Coulombe G; Ahmed S; Kuk J; Dar AR; Mahmud A; Fairchild A; Wilson CF; Wu JSY; Dennis K; DeAngelis C; Wong RKS; Zhu L; Chow E
    Am J Hosp Palliat Care; 2018 Apr; 35(4):718-723. PubMed ID: 28950727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pain flare following external beam radiotherapy and meaningful change in pain scores in the treatment of bone metastases.
    Chow E; Ling A; Davis L; Panzarella T; Danjoux C
    Radiother Oncol; 2005 Apr; 75(1):64-9. PubMed ID: 15878102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pain flare in patients with bone metastases after palliative radiotherapy--a nested randomized control trial.
    Loblaw DA; Wu JS; Kirkbride P; Panzarella T; Smith K; Aslanidis J; Warde P
    Support Care Cancer; 2007 Apr; 15(4):451-5. PubMed ID: 17093912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of an electronic quality checklist on prescription patterns of prophylactic antiemetic and pain flare medications in the context of palliative radiotherapy for bone metastases.
    Gaudet M; Linden K; Renaud J; Samant R; Dennis K
    Support Care Cancer; 2020 Sep; 28(9):4487-4492. PubMed ID: 31933067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of a dedicated palliative radiation oncology service on the use of single fraction and hypofractionated radiation therapy among patients with bone metastases.
    Skamene S; Agarwal I; Makar M; Krishnan M; Spektor A; Hertan L; Mouw KW; Taylor A; Noveroske Philbrick S; Balboni T
    Ann Palliat Med; 2018 Apr; 7(2):186-191. PubMed ID: 29307209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of Pain Palliation After Radiation Therapy for Painful Tumors: A Prospective Observational Study.
    Saito T; Toya R; Tomitaka E; Matsuyama T; Ninomura S; Oya N
    Int J Radiat Oncol Biol Phys; 2018 Aug; 101(5):1061-1068. PubMed ID: 29885995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.